UNFOLDMENT OF

COLLECTIVE CONSCIOUSNESS

Bhaswat S. Chakraborty

Senior Vice President, Research & Development

Cadila Pharmaceuticals Ltd.,

Dholka – 387 910, Ahmedabad, Gujarat, India

Dr. Bhaswat S. Chakraborty graduated with a BPharm (Hons.) from Banaras Hindu University, following which he attended University of Saskatchewan, Canada with an award of a Graduate Scholarship, where he completed a PhD in Pharmacokinetics of anti-psychotic drugs. Following his post doctoral fellowship and a brief spell of teaching at University of Saskatchewan, Saskatoon, Canada, Dr. Chakraborty joined the Health Protection Branch, Ministry of Health, Government of Canada as a Senior Clinical Reviewer of the New Drug Applications and was located in Ottawa. He served there in various capacities for seven years including the acting Head of Biopharmaceutics Evaluation and Head of Chemistry & Manufacturing. In these roles, he has evaluated more than 300 Abbreviated New Drug Applications and 20 Pharmacokinetics based New Drug Applications.

In 1997, Dr. Chakraborty joined Biovail Corporation International, Toronto as the Director of Biopharmaceutics and served there until beginning of 2000, where he designed and investigated more than 250 Phase I and 12 higher Phase Clinical Studies for the FDA, TPP, EU and other Agencies.

An eminent speaker, Dr. Chakraborty is currently the Senior Vice President – Research & Development at Cadila Pharmaceuticals Ltd., Ahmedabad. He is also an author and co-author of more than 40 scientific papers and abstracts in refereed international journals. In addition, Dr. Chakraborty is the Founder of a Spiritual Association; an External Examiner of MSc Courses and Theses in Biochemistry & Drug Metabolism at Nirma University, Ahmedabad, India; and also on the board of several Institutes and Universities in India in various capacities.